{
    "clinical_study": {
        "@rank": "95925", 
        "arm_group": {
            "arm_group_label": "CHC patients"
        }, 
        "brief_summary": {
            "textblock": "This observational study will examine the efficacy and safety of Pegasys (peginterferon\n      alfa-2a), mostly in combination with Copegus (ribavirin) treatment in CHC patients. Quality\n      of care will also be assessed. Approximately 12% of the interferon-treated chronic hepatitis\n      C (CHC) patient population in Germany is expected to be studied over a period of 5 years."
        }, 
        "brief_title": "Observational Study Evaluating the Quality of Pegasys and Copegus Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Hepatitis C", 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis, Chronic", 
                "Hepatitis C", 
                "Hepatitis C, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age or over\n\n          -  Clinically diagnosed CHC with detectable virus replication\n\n          -  Use of effective contraception as defined in the protocol throughout the study until\n             4 months after end of treatment\n\n        Exclusion Criteria:\n\n          -  Any contraindications for Pegasys or ribavirin treatment\n\n          -  Pregnant or breast-feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with CHC eligible for Pegasys treatment"
            }
        }, 
        "enrollment": {
            "#text": "9729", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02106156", 
            "org_study_id": "ML21645"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Herne", 
                    "country": "Germany", 
                    "zip": "44623"
                }
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Noninterventional Study for Quality Assurance in Therapy of Chronic Hepatitis C With Peg-(40kd)-Interferon Alfa-2a (Pegasys) and Ri-bavirin (i.e. Copegus) at Hepatology Centers- a Project in Cooperation With BNG (Association of German Resident Gastroenterologists, Part III)", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Rapid virologic response (RVR)", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }, 
            {
                "measure": "Early virologic response (EVR)", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }, 
            {
                "measure": "End of treatment response (EOT)", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }, 
            {
                "measure": "Sustained virologic response (SVR)", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }, 
            {
                "measure": "Incidence of severe adverse events", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02106156"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Patient demographics", 
                "safety_issue": "No", 
                "time_frame": "At Baseline (Day 1)"
            }, 
            {
                "measure": "Hepatitis C medical history", 
                "safety_issue": "No", 
                "time_frame": "At Baseline (Day 1)"
            }, 
            {
                "measure": "Treatment/dosage data", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }, 
            {
                "measure": "Viral genotype", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }, 
            {
                "measure": "Viral load", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }, 
            {
                "measure": "Concomitant treatment information (medication type, dosage)", 
                "safety_issue": "No", 
                "time_frame": "1.5 years"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}